Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma
Article in Radiotherapy and Oncology (December 2023)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
Book chapter (November 2023)
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Article in Advanced Drug Delivery Reviews (April 2023)